Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2007
11/21/2007EP1363594B1 Cosmetic formulations containing flavonoid derivatives
11/21/2007EP1356071B1 Genetically engineered herpes virus for the treatment of cardiovascular disease
11/21/2007EP1301500B1 Nitrosated and nitrosylated taxanes, compositions and methods of use
11/21/2007EP1269196B1 Method of screening for inhibitors of osteopontin
11/21/2007EP1263958B1 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
11/21/2007EP1200459B1 Compounds for treatment of infectious and immune system disorders and methods for their use
11/21/2007EP1019087B1 Ganglioside immunostimulating complexes and uses thereof
11/21/2007EP0842196B1 Cell adhesion inhibitors
11/21/2007EP0522091B9 Use of a mbp peptide for the preparation of a medicament for the treatment of multiple sclerosis
11/21/2007CN101076325A Medicinal composition of edible carboxylic-acid and/or its acid salts and caffeine and non-drug addiction coffee
11/21/2007CN101074415A Acanthopanax-root wine and its production
11/21/2007CN101074267A Transduced peptide-humanized granular leukocyte macrophage colony stimulating factor fusion protein and its medicinal composition
11/21/2007CN101074266A Transduced peptide-humanized granular leukocyte colony stimulating factor fusion protein and its medicinal composition
11/21/2007CN101074210A Pharmaceutically active isoindoline derivatives
11/21/2007CN101073667A Enhancer for antibody to lymphocytic tumors
11/21/2007CN101073427A Glossy ganoderma cordycepin beverage and its production
11/21/2007CN101073410A Functional food
11/21/2007CN101073409A Multipurpose medicinal edible food
11/21/2007CN100349920C Ganalioside-associated recombinant antibodies and use thereof in diagnosis and treatment of tumours
11/21/2007CN100349887C Substituted 4-aryl-4H-pyrrolo[2,3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/21/2007CN100349862C 大麻素受体配体 Cannabinoid receptor ligands
11/21/2007CN100349632C Microprojection array having beneficial agent contg coating
11/21/2007CN100349627C Medical devices containing rapamycin analogs
11/21/2007CN100349600C Chinese medicinal compositino for fortifying immunity, improving anoxia tolerance and its preparation method
11/21/2007CN100349590C Medicinal use of glutinous rehmannia stem and leaf and its extract for preventing asthma and anti-allergy
11/21/2007CN100349589C Medical application of rehmannia root extractive in resisting asthma and allergy
11/21/2007CN100349579C Composition of ginseng-astragalus polysaccharides and its preparing method
11/21/2007CN100349562C Ophthalmic drug delivery device
11/20/2007US7297818 Adamantane derivatives
11/20/2007US7297792 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
11/20/2007US7297763 Mixture of IGF-1 and N,N-bis(3-D-gluconamidopropyl)-deoxycholamine that binds specifically to IGF-1 and blocks binding of IGFBP-1 and IGFBP-3; used as a standard for identifying IGF-1 indirect agonists
11/20/2007US7297703 Macrolides
11/20/2007US7297696 Antiarthritic agents; antihistamines; atherosclerosis; multiple sclerosis; Crohn's disease; nephritis; pancreastitis; skin disorders; restenosis; prevent leukocyte migration
11/20/2007US7297692 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
11/20/2007US7297681 For use in therapy of growth metabolic disorders
11/20/2007US7297676 Thymosin alpha 1 peptide/polymer conjugates
11/20/2007US7297542 Virology and gene therapy; modified fiber knob retains its ability to trimerize and retains its native biosynthesis profile
11/20/2007US7297523 Human elongase genes and uses thereof
11/20/2007US7297509 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
11/20/2007US7297338 Genetic engineered mutant microorganisms ; synergistic mixture
11/20/2007US7297330 Low dose haptenized tumor cell and tumor cell extract immunotherapy
11/20/2007CA2451754C Thienothiazine compounds having anti-inflammatory and analgesic activities and their preparation methods and the use thereof
11/20/2007CA1341561C Manufacture and expression of large structural genes
11/15/2007WO2007131154A2 Using naltrexone as a multi-purpose health supplement to improve the human condition and preventing multiple diseases and infirmities by stimulating immune system vitality and robustness
11/15/2007WO2007129745A1 Heteroarylamide lower carboxylic acid derivative
11/15/2007WO2007129743A1 Anti-inflammatory composition
11/15/2007WO2007129473A1 Bicyclic aryl derivative
11/15/2007WO2007129406A1 Degranulation inhibitor
11/15/2007WO2007129040A1 p38 MAP KINASE INHIBITORS
11/15/2007WO2007128782A1 Spiro- (tho) benzopyran-2, 4' -piperidine-and cyclohexane derivatives as inhibitors of specific cell cycle enzymes
11/15/2007WO2007128564A2 Use of a compound with rankl activity
11/15/2007WO2007128482A1 Use of a b-cell-depleting antibody for treatment of polyoma virus infections
11/15/2007WO2007128344A1 Design and synthesis of biotinylated probes for n-acyl-ethanolamines
11/15/2007WO2007128115A1 Immune privileged and modulatory progenitor cells
11/15/2007WO2007108763B1 Use of lactobacillus strains for promoting immunotolerance in autoimmune disease
11/15/2007WO2007085815A3 Ligands that bind il-4 and/or il-13
11/15/2007WO2007084693A3 Immunoconjugates with improved efficacy for the treatment of diseases
11/15/2007US20070265449 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
11/15/2007US20070265345 Novel Biphenyl Compounds And Their Use
11/15/2007US20070265327 For therapy of neurodegenerative and/or neurological disorders, e.g., Alzheimer's disease, in a mammal
11/15/2007US20070265320 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity
11/15/2007US20070265299 Compounds for the treatment of inflammatory disorders
11/15/2007US20070265296 Nuclear receptor binding agents
11/15/2007US20070265291 2-(3-{6-[2-(2,4-dichloro-phenyl)-ethylamino]-2-methoxy-pyrimidin-4-yl}-phenyl)-2-methyl-propionic acid; allergic disease; systemic mastocytosis, disorders accompanied by systemic mast cell activation, anaphylaxis shock, bronchoconstriction, bronchitis, urticaria, eczema, diseases accompanied by itch
11/15/2007US20070265289 2-Aminopyrimidine Derivative
11/15/2007US20070265286 Quinazoline derivatives as VEGF inhibitors
11/15/2007US20070265280 Methods of using sodium channel blockers
11/15/2007US20070265278 2-phenyl-indoles as prostaglandin d2 receptor antagonists
11/15/2007US20070265273 Pyrimidin-2-Amine Derivatives and Their Use as A2b Adenosine Receptor Antagonists
11/15/2007US20070265263 Heterocyclic inhibitors of ERK2 and uses thereof
11/15/2007US20070265257 Morpholine Compound
11/15/2007US20070265250 Imidazole compounds
11/15/2007US20070265208 Association of calpain inhibitors and reactive oxygen species trapping agents
11/15/2007US20070265201 Inhibitors of inflammatory cytokine transcription derived from hcmv protein ie2
11/15/2007US20070265191 Pharmaceutical compositions and methods for peptide treatment
11/15/2007US20070264417 Procyanidins; cleaning cocoa beans, heating unroasted cocoa nibs to loosen shells, winnowing the nibs from the shells, extracting with a polar solvent, a non-polar solvent, or a supercritical fluid
11/15/2007US20070264287 Methods for Increasing the Immune Response in an Animal
11/15/2007US20070264282 Herpes virus strains for gene therapy
11/15/2007US20070264278 Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Aureus
11/15/2007US20070264275 Peptides Derived from the Protein Mmp-2, and the Use Thereof in Antitumoral Immunotherapy
11/15/2007US20070264273 Sphingoid polyalklamine conjugates, isomers and uses thereof
11/15/2007US20070264271 Potent Immunostimulatory from Microalgae
11/15/2007US20070264270 Endometriosis markers
11/15/2007US20070264260 Treatment methods using anti-CD22 antibodies
11/15/2007US20070264257 Immunotherapy of autoimmune disorders
11/15/2007US20070264230 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
11/15/2007DE19544507B4 Cyclosporin enthaltende Präparate Cyclosporin-containing preparations
11/15/2007CA2651201A1 Use of a compound with rankl activity
11/15/2007CA2650970A1 P38 map kinase inhibitors
11/15/2007CA2649874A1 Immune privileged and modulatory progenitor cells
11/15/2007CA2648831A1 Spiro- (tho) benzopyran-2, 4' -piperidine-and cyclohexane derivatives as inhibitors of specific cell cycle enzymes
11/14/2007EP1854885A2 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/14/2007EP1854884A2 Immunosuppression by blocking T cell co-stimulation signal 2 (B7/CD28 interaction)
11/14/2007EP1854793A1 NOVEL AMINOPYRIDINE COMPOUND WITH Syk INHIBITORY ACTIVITY
11/14/2007EP1854480A2 Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
11/14/2007EP1854479A2 Recombinant or purified polyclonal antibodies for treating allergy
11/14/2007EP1854474A1 Immunopotentiating agent
11/14/2007EP1854472A1 Support for protein transfer, protein transfer agent using the support, protein transfer method, cell having protein transferred thereinto and method of producing the same
11/14/2007EP1854469A1 Fermentation composition having immunomodulating effect
11/14/2007EP1854467A1 Composition for immune activation
1 ... 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 ... 1172